Skip to main content
PLOS One logoLink to PLOS One
. 2015 Jun 29;10(6):e0132230. doi: 10.1371/journal.pone.0132230

Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs

The PLOS ONE Staff
PMCID: PMC4488309  PMID: 26121339

Notice of Republication

This article was republished on June 15, 2015, to correct an error in the title. The publisher apologizes for the error. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished, corrected article.

(PDF)

Reference

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished, corrected article.

(PDF)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES